The Latest From CureMatch
CureMatch’s co-founder and Chief Science Officer, Dr. Igor Tsigelny contributed to recently published cancer research concerning impact of viruses HTLV-1 and BLV on development of various cancers which could prove helpful to future CureMatch work. Findings are hopeful that it may be possible to eradicate these viruses acceleration of various cancers. The human T-cell leukemia […]
San Diego, CA (USA), Paris (France), – WeHealth by Servier, Servier Group’s e-health department, and CureMatch, a leader in digital health precision medicine announce a partnership to jointly bring the CureMatch digital platform to oncologists, clinics and hospitals around the world. We’ve been working with oncologists closely the past few years and understand they face a […]
Tune in to the J&J Innovation Podcast series featuring CureMatch’s Stephane Richard. J&J’s host, Caroline Baratz goes in depth to discover more about the people behind innovative companies ushering in the latest trends in healthcare.
CureMatch shares theories of 'Kolmogorov Complexity' to optimize descriptor selection at AIMed Summit. Just as a picture is worth a thousand words, a single descriptor can have the information content of a thousand descriptors embedded in it. The CureMatch presentation, titled ‘Kolmogorov Complexity, Logical Depth, etc. in Selection of Descriptors for Deep Learning in Medicine’ was given by Igor Tsigelny, Ph.D and Eden Romm, B.S.
When it comes to cancer treatment in Mexico, just like in the United States, many cancer patients and their doctors still rely on traditional “one-size-fits-all” methods of care. CureMatch is looking to extend Precision Medicine technology to doctors and facilities responsible for any cancer treatment in Mexico.